Dental implant treatment for renal failure patients on dialysis: a clinical guideline

Abstract

New clinical guidelines aim to ensure safer dental implant procedures for patients on dialysis for kidney failure. Chronic kidney disease is becoming more common, and 90% of patients experience oral symptoms that lead to early tooth loss. Dental implants can greatly improve quality of life, but carry increased risk of infections for dialysis patients because of their compromised immune systems. Dr. Yuan at Sichuan University, Chengdu, China, and experts from other 4 countries have produced comprehensive clinical guidelines for installing dental implants in dialysis patients. They stress that dentists should consult kidney specialists early in the process, systematically review patient history and perform extensive blood tests prior to surgery. The procedure itself should be as simple and non-invasive as possible, and prophylactic antibiotics should be taken post-operation to minimize infection risk and complications with dialysis.

Keywords

chronic kidney disease / dental implant / hemodialysis / osseointegration / renal failure

References

[1] Jha V, Garcia-Garcia G, Iseki K. Chronic kidney disease: global dimension and perspectives. Lancet, 2013, 382(9888): 260-272.

[2] Saran R, Hedgeman E, Huseini M. Surveillance of chronic kidney disease around the world: tracking and reining in a global problem. Adv Chronic Kidney Dis, 2010, 17(3): 271-281.

[3] Mills KT, Xu Y, Zhang W. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int, 2015, 88(5): 950-957.

[4] Couser WG, Remuzzi G, Mendis S. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int, 2011, 80(12): 1258-1270.

[5] Zhang L, Wang F, Wang L. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 379(9818): 815-822.

[6] Coresh J, Selvin E, Stevens LA. Prevalence of chronic kidney disease in the United States. JAMA, 2007, 298(17): 2038-2047.

[7] Davidovich E, Davidovits M, Eidelman E. Pathophysiology, therapy, and oral implications of renal failure in children and adolescents: an update. Pediatr Dent, 2005, 27(2): 98-106.

[8] De Rossi SS, Glick M. Dental considerations for the patient with renal disease receiving hemodialysis. J Am Dent Assoc, 1996, 127(2): 211-219.

[9] Xie T, Yang Z, Dai G. Evaluation of the oral health status in Chinese hemodialysis patients. Hemodial Int, 2014, 18(3): 668-673.

[10] Jover Cervero A, Bagan JV, Jimenez Soriano Y. Dental management in renal failure: patients on dialysis. Med Oral Patol Oral Cir Bucal, 2008, 13(7): E419-E426.

[11] Proctor R, Kumar N, Stein A. Oral and dental aspects of chronic renal failure. J Dent Res, 2005, 84(3): 199-208.

[12] Limeres J, Garcez JF, Marinho JS. Early tooth loss in end-stage renal disease patients on haemodialysis. Oral Dis, 2016, 22(6): 530-535.

[13] Szeto HH, Inturrisi CE, Houde R. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med, 1977, 86(6): 738-741.

[14] Craig RG, Kotanko P, Kamer AR. Periodontal diseases—a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy?. Nephrol Dial Transplant, 2007, 22(2): 312-315.

[15] Stellingsma C, Vissink A, Meijer HJ. Implantology and the severely resorbed edentulous mandible. Crit Rev Oral Biol Meds, 2004, 15(4): 240-248.

[16] Liu W, Kang N, Seriwatanachai D. Chronic kidney disease impairs bone defect healing in rats. Sci Rep, 2016, 6: 23041.

[17] Zou H, Zhao X, Sun N. Effect of chronic kidney disease on the healing of titanium implants. Bone, 2013, 56(2): 410-415.

[18] Stevens PE, Levin A Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med, 2013, 158(11): 825-830.

[19] Levey AS, de Jong PE, Coresh J. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int, 2011, 80(1): 17-28.

[20] National Kidney F K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266.

[21] Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis, 2009, 53(3 Suppl 3): S4-S16.

[22] Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet, 2005, 365(9456): 331-340.

[23] Kao WH, Klag MJ, Meoni LA. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet, 2008, 40(10): 1185-1192.

[24] Kanji Z, Powe CE, Wenger JB. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol, 2011, 22(11): 2091-2097.

[25] Albert DA, Ward A, Allweiss P. Diabetes and oral disease: implications for health professionals. Ann N Y Acad Sci, 2012, 1255: 1-15.

[26] Habib Khan Y, Sarriff A, Hayat Khan A. Infective endocarditis and chronic kidney disease: how to deal with complications. Malays J Med Sci, 2015, 22(4): 73-75.

[27] American Diabetes A Diagnosis and classification of diabetes mellitus. Diabetes Care, 2012, 35(Suppl 1): S64-S71.

[28] Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol, 2001, 6(1): 99-112.

[29] Wu YY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. Int J Oral Sci, 2015, 7(2): 63-72.

[30] Fox CS, Matsushita K, Woodward M. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet, 2012, 380(9854): 1662-1673.

[31] Webster AC, Nagler EV, Morton RL. Chronic kidney disease. Lancet, 2017, 389(10075): 1238-1252.

[32] Savica V, Bellinghieri G, Monardo P. An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts. J Nephrol, 2013, 26(3): 456-464.

[33] Davidovich E, Schwarz Z, Davidovitch M. Oral findings and periodontal status in children, adolescents and young adults suffering from renal failure. J Clin Periodontol, 2005, 32(10): 1076-1082.

[34] Souza CM, Braosi AP, Luczyszyn SM. Oral health in Brazilian patients with chronic renal disease. Rev Med Chil, 2008, 136(6): 741-746.

[35] Tadakamadla J, Kumar S, Mamatha GP. Comparative evaluation of oral health status of chronic kidney disease (CKD) patients in various stages and healthy controls. Spec Care Dentist, 2014, 34(3): 122-126.

[36] Klassen JT, Krasko BM. The dental health status of dialysis patients. J Can Dent Assoc, 2002, 68(1): 34-38.

[37] Locsey L, Alberth M, Mauks G. Dental management of chronic haemodialysis patients. Int Urol Nephrol, 1986, 18(2): 211-213.

[38] Lopez-Pintor RM, Lopez-Pintor L, Casanas E. Risk factors associated with xerostomia in haemodialysis patients. Med Oral Patol Oral Cir Bucal, 2017, 22(2): e185-e192.

[39] Eigner TL, Jastak JT, Bennett WM. Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc, 1986, 113(4): 612-616.

[40] Suresh G, Ravi Kiran A, Samata Y. Analysis of blood and salivary urea levels in patients undergoing haemodialysis and kidney transplant. J Clin Diagn Res, 2014, 8(7): ZC18-ZC20.

[41] Peng CH, Xia YC, Wu Y. Influencing factors for saliva urea and its application in chronic kidney disease. Clin Biochem, 2013, 46(3): 275-277.

[42] Venkatapathy R, Govindarajan V, Oza N. Salivary creatinine estimation as an alternative to serum creatinine in chronic kidney disease patients. Int J Nephrol, 2014, 2014: 724-742.

[43] Tomas I, Marinho JS, Limeres J. Changes in salivary composition in patients with renal failure. Arch Oral Biol, 2008, 53(6): 528-532.

[44] Savica V, Calo L, Santoro D. Salivary phosphate secretion in chronic kidney disease. J Ren Nutr, 2008, 18(1): 87-90.

[45] Subramaniam P, Gupta M, Mehta A. Oral health status in children with renal disorders. J Clin Pediatr Dent, 2012, 37(1): 89-93.

[46] Jaffe EC, Roberts GJ, Chantler C. Dental findings in chronic renal failure. Br Dent J, 1986, 160(1): 18-20.

[47] Martins C, Siqueira WL, Oliveira E. Dental calculus formation in children and adolescents undergoing hemodialysis. Pediatr Nephrol, 2012, 27(10): 1961-1966.

[48] Trainor D, Borthwick E, Ferguson A. Perioperative management of the hemodialysis patient. Semin Dial, 2011, 24(3): 314-326.

[49] Davidovich E, Davidovits M, Peretz B. The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease. Nephrol Dial Transplant, 2009, 24(8): 2439-2445.

[50] Lucas VS, Roberts GJ. Oro-dental health in children with chronic renal failure and after renal transplantation: a clinical review. Pediatr Nephrol, 2005, 20(10): 1388-1394.

[51] Sobrado Marinho JS, Tomas Carmona I, Loureiro A. Oral health status in patients with moderate-severe and terminal renal failure. Med Oral Patol Oral Cir Bucal, 2007, 12(4): E305-E310.

[52] Zhao D, Zhang S, Chen X. Evaluation of periodontitis and bone loss in patients undergoing hemodialysis. J Periodontol, 2014, 85(11): 1515-1520.

[53] Ciavarella D, Guiglia R, Campisi G. Update on gingival overgrowth by cyclosporine A in renal transplants. Med Oral Patol Oral Cir Bucal, 2007, 12(1): E19-E25.

[54] Kho HS, Lee SW, Chung SC. Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999, 88(3): 316-319.

[55] Jaffe EC, Roberts GJ, Cahntler C. Dental maturity in children with chronic renal failure assessed from dental panoramic tomographs. J Int Assoc Dent Child, 1990, 20(2): 54-58.

[56] Martins C, Siqueira WL, Guimaraes Primo LS. Oral and salivary flow characteristics of a group of Brazilian children and adolescents with chronic renal failure. Pediatr Nephrol, 2008, 23(4): 619-624.

[57] Galili D, Berger E, Kaufman E. Pulp narrowing in renal end stage and transplanted patients. J Endod, 1991, 17(9): 442-443.

[58] Nasstrom K, Forsberg B, Petersson A. Narrowing of the dental pulp chamber in patients with renal diseases. Oral Surg Oral Med Oral Pathol, 1985, 59(3): 242-246.

[59] Al-Nowaiser A, Roberts GJ, Trompeter RS. Oral health in children with chronic renal failure. Pediatr Nephrol, 2003, 18(1): 39-45.

[60] Nakhjavani YB, Bayramy A. The dental and oral status of children with chronic renal failure. J Indian Soc Pedod Prev Dent, 2007, 25(1): 7-9.

[61] Nunn JH, Sharp J, Lambert HJ. Oral health in children with renal disease. Pediatr Nephrol, 2000, 14(10/11): 997-1001.

[62] Bots CP, Poorterman JH, Brand HS. The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Dis, 2006, 12(2): 176-180.

[63] Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2004, 97(1): 28-46.

[64] de la Rosa Garcia E, Mondragon Padilla A, Aranda Romo S. Oral mucosa symptoms, signs and lesions, in end stage renal disease and non-end stage renal disease diabetic patients. Med Oral Patol Oral Cir Bucal, 2006, 11(6): E467-E473.

[65] Fishbane S, Nissenson AR. Anemia management in chronic kidney disease. Kidney Int Suppl, 2010, 117: S3-S9.

[66] Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol, 1996, 23(3 Pt 1): 194-202.

[67] King GN, Healy CM, Glover MT. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol, 1994, 78(6): 718-726.

[68] Greenspan JS, Greenspan D. Oral hairy leukoplakia: diagnosis and management. Oral Surg Oral Med Oral Pathol, 1989, 67(4): 396-403.

[69] de la Rosa-Garcia E, Mondragon-Padilla A, Irigoyen-Camacho ME. Oral lesions in a group of kidney transplant patients. Med Oral Patol Oral Cir Bucal, 2005, 10(3): 196-204.

[70] Olivas-Escarcega V, Rui-Rodriguez Mdel S, Fonseca-Leal Mdel P. Prevalence of oral candidiasis in chronic renal failure and renal transplant pediatric patients. J Clin Pediatr Dent, 2008, 32(4): 313-317.

[71] Leao JC, Gueiros LA, Segundo AV. Uremic stomatitis in chronic renal failure. Clinics (Sao Paulo), 2005, 60(3): 259-262.

[72] McCreary CE, Flint SR, McCartan BE. Uremic stomatitis mimicking oral hairy leukoplakia: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997, 83(3): 350-353.

[73] Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009: (113): S1–S130.

[74] Wu Q, Lai X, Zhu Z. Evidence for chronic kidney disease-mineral and bone disorder associated with metabolic pathway changes. Medicine (Baltimore), 2015, 94(32): e1273.

[75] Moe S, Drueke T, Cunningham J. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006, 69(11): 1945-1953.

[76] Miller PD. Chronic kidney disease and the skeleton. Bone Res, 2014, 2: 14044.

[77] Ganibegovic M. Dental radiographic changes in chronic renal disease. Med Arh, 2000, 54(2): 115-118.

[78] Michiwaki Y, Michi K, Yamaguchi A. Marked enlargement of the jaws in secondary hyperparathyroidism—a case report. Int J Oral Maxillofac Surg, 1996, 25(1): 54-56.

[79] Raubenheimer EJ, Noffke CE, Mohamed A. Expansive jaw lesions in chronic kidney disease: review of the literature and a report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 119(3): 340-345.

[80] Kerr AR. Update on renal disease for the dental practitioner. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2001, 92(1): 9-16.

[81] Krishnan M. Preoperative care of patients with kidney disease. Am Fam Physician, 2002, 66(8): 1471-1476.

[82] Shah R, Haddad N, Vachharajani TJ. Thrombocytopenia in ESRD patients: epidemiology, mechanisms and interventional nephrology perspective. Semin Dial, 2014, 27(6): 618-625.

[83] Ward LM, Rauch F, White KE. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone, 2004, 34(5): 905-911.

[84] Holick MF. Vitamin D deficiency. N Engl J Med, 2007, 357(3): 266-281.

[85] National Kidney F K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 2003, 42(4 Suppl 3): S1-S201.

[86] Opatrny K Jr. Hemostasis disorders in chronic renal failure. Kidney Int Suppl, 1997, 62: S87-S89.

[87] Stewart JH. Platelet numbers and life span in acute and chronic renal failure. Thromb Diath Haemorrh, 1967, 17(3/4): 532-542.

[88] Precious DS, Laba JP, Hinrichsen GJ. Dental considerations for patients on chronic dialysis and renal transplant recipients. J Can Dent Assoc, 1981, 47(9): 595-599.

[89] Buckley DJ, Barrett AP, Koutts J. Control of bleeding in severely uremic patients undergoing oral surgery. Oral Surg Oral Med Oral Pathol, 1986, 61(6): 546-549.

[90] Naylor GD, Fredericks MR. Pharmacologic considerations in the dental management of the patient with disorders of the renal system. Dent Clin North Am, 1996, 40(3): 665-683.

[91] Yoshiko Y, Wang H, Minamizaki T. Mineralized tissue cells are a principal source of FGF23. Bone, 2007, 40(6): 1565-1573.

[92] Mirams M, Robinson BG, Mason RS. Bone as a source of FGF23: regulation by phosphate?. Bone, 2004, 35(5): 1192-1199.

[93] Wang H, Yoshiko Y, Yamamoto R. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res, 2008, 23(6): 939-948.

[94] Shalhoub V, Ward SC, Sun B. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int, 2011, 89(2): 140-150.

[95] Gutierrez O, Isakova T, Rhee E. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol, 2005, 16(7): 2205-2215.

[96] Larsson T, Nisbeth U, Ljunggren O. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int, 2003, 64(6): 2272-2279.

[97] Prie D, Urena Torres P, Friedlander G. Latest findings in phosphate homeostasis. Kidney Int, 2009, 75(9): 882-889.

[98] Komaba H, Fukagawa M. FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int, 2010, 77(4): 292-298.

[99] Guo YC, Yuan Q. Fibroblast growth factor 23 and bone mineralisation. Int J Oral Sci, 2015, 7(1): 8-13.

[100] Lau WL, Kalantar-Zadeh K. Why is the association of phosphorus and FGF23 with mortality stronger in African-American hemodialysis patients. Am J Nephrol, 2015, 42(1): 22-24.

[101] Sharaf El Din UA, Salem MM, Abdulazim DO. FGF23 and inflammation. World J Nephrol, 2017, 6(1): 57-58.

[102] Sun N, Guo Y, Liu W. FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice. Sci Rep, 2015, 5: 8304.

[103] Yuan Q, Jiang Y, Zhao X. Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice. J Bone Miner Res, 2014, 29(3): 693-704.

[104] Zhu N, Wang J, Gu L. Vitamin D supplements in chronic kidney disease. Ren Fail, 2015, 37(6): 917-924.

[105] Veldurthy V, Wei R, Oz L. Vitamin D, calcium homeostasis and aging. Bone Res, 2016, 4: 16041.

[106] Busse B, Bale HA, Zimmermann EA. Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture. Sci Transl Med, 2013, 5(193): 193ra88.

[107] Eckardt KU, Kasiske BL. Kidney disease: improving global outcomes. Nat Rev Nephrol, 2009, 5(11): 650-657.

[108] Restrepo Valencia CA, Aguirre Arango JV. Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5. Colomb Med (Cali), 2016, 47(3): 160-166.

[109] Liu W, Zhang S, Zhao D. Vitamin D supplementation enhances the fixation of titanium implants in chronic kidney disease mice. PLoS One, 2014, 9(4): e95689.

[110] Abbassy MA, Watari I, Bakry AS. Calcitonin and vitamin D3 have high therapeutic potential for improving diabetic mandibular growth. Int J Oral Sci, 2016, 8(1): 39-44.

[111] Blau JE, Collins MT. The PTH-vitamin D-FGF23 axis. Rev Endocr Metab Disord, 2015, 16(2): 165-174.

[112] Horner K, O'Malley L, Taylor K. Guidelines for clinical use of CBCT: a review. Dentomaxillofac Radiol, 2015, 44(1): 20140225.

[113] Zhao D, Chen X, Yue L. Assessment of residual alveolar bone volume in hemodialysis patients using CBCT. Clin Oral Investig, 2015, 19(7): 1619-1624.

[114] Leonard A, Raij L, Shapiro FL. Bacterial endocarditis in regularly dialyzed patients. Kidney Int, 1973, 4(6): 407-422.

[115] Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant, 2004, 19(6): 1360-1362.

[116] Doulton T, Sabharwal N, Cairns HS. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int, 2003, 64(2): 720-727.

[117] Lam DK, Jan A, Sandor GK. Prevention of infective endocarditis: revised guidelines from the American Heart Association and the implications for dentists. J Can Dent Assoc, 2008, 74(5): 449-453.

[118] Gupta M, Gupta M, Abhishek. Oral conditions in renal disorders and treatment considerations—a review for pediatric dentist. Saudi Dent J, 2015, 27(3): 113-119.

[119] Farbod F, Kanaan H, Farbod J. Infective endocarditis and antibiotic prophylaxis prior to dental/oral procedures: latest revision to the guidelines by the American Heart Association published April 2007. Int J Oral Maxillofac Surg, 2009, 38(6): 626-631.

[120] Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician, 2007, 75(10): 1487-1496.

[121] Drayer DE. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin Pharmacokinet, 1976, 1(6): 426-443.

[122] Jameson MD, Wiegmann TB. Principles, uses, and complications of hemodialysis. Med Clin North Am, 1990, 74(4): 945-960.

[123] Prabhakar, Singh RG, Singh S. Spectrum of intradialytic complications during hemodialysis and its management: a single-center experience. Saudi J Kidney Dis Transpl, 2015, 26(1): 168-172.

[124] Seidl C, Eberle B. How to perform safe anesthesia in patients with end-stage renal disease. Contrib Nephrol, 2015, 184: 107-122.

[125] Hallonsten AL. The use of oral sedatives in dental care. Acta Anaesthesiol Scand Suppl, 1988, 88: 27-30.

[126] Harbuz DK, O'Halloran M. Techniques to administer oral, inhalational, and IV sedation in dentistry. Australas Med J, 2016, 9(2): 25-32.

[127] Szymanska J. Environmental health risk of chronic exposure to nitrous oxide in dental practice. Ann Agric Environ Med, 2001, 8(2): 119-122.

[128] Sowell SB. Dental care for patients with renal failure and renal transplants. J Am Dent Assoc, 1982, 104(2): 171-177.

[129] Liu YK, Kosfeld RE, Marcum SG. Treatment of uraemic bleeding with conjugated oestrogen. Lancet, 1984, 2(8408): 887-890.

[130] Sindet-Pedersen S, Stenbjerg S. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofac Surg, 1986, 44(9): 703-707.

[131] Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med, 2004, 351(7): 683-694.

[132] Lockhart PB, Gibson J, Pond SH. Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease. Br Dent J, 2003, 195(8): 439-445.

[133] Katz JO, Terezhalmy GT. Dental management of the patient with hemophilia. Oral Surg Oral Med Oral Pathol, 1988, 66(1): 139-144.

[134] Kraus ES, Parekh RS, Oberai P. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant, 2009, 9(8): 1826-1834.

[135] Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med, 2003, 253(6): 643-652.

[136] Levey AS, Coresh J. Chronic kidney disease. Lancet, 2012, 379(9811): 165-180.

[137] Herrero-Climent M, Albertini M, Rios-Santos JV. Resonance frequency analysis-reliability in third generation instruments: Osstell mentor®. Med Oral Patol Oral Cir Bucal, 2012, 17(5): e801-e806.

[138] Bragger U. Use of radiographs in evaluating success, stability and failure in implant dentistry. Periodontol 2000, 1998, 17: 77-88.

[139] Costa LC, Costa FO, Cortelli SC. Gingival overgrowth in renal transplant subjects: a 44-month follow-up study. Transplantation, 2013, 96(10): 890-896.

[140] Chrcanovic BR, Kisch J, Albrektsson T. Factors influencing early dental implant failures. J Dent Res, 2016, 95(9): 995-1002.

[141] Smeets R, Henningsen A, Jung O. Definition, etiology, prevention and treatment of peri-implantitis—a review. Head Face Med, 2014, 10: 34.

[142] Bryce G, MacBeth N. Vitamin D deficiency as a suspected causative factor in the failure of an immediately placed dental implant: a case report. J R Nav Med Serv, 2014, 100(3): 328-332.

[143] Khammissa RA, Feller L, Meyerov R. Peri-implant mucositis and peri-implantitis: clinical and histopathological characteristics and treatment. SADJ, 2012, 67(3): 124-126.

[144] Romeo E, Ghisolfi M, Murgolo N. Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part I: clinical outcome. Clin Oral Implants Res, 2005, 16(1): 9-18.

[145] Guobis Z, Pacauskiene I, Astramskaite I. General diseases influence on peri-implantitis development: a systematic review. J Oral Maxillofac Res, 2016, 7(3): e5.

[146] Naujokat H, Kunzendorf B, Wiltfang J. Dental implants and diabetes mellitus—a systematic review. Int J Implant Dent, 2016, 2(1): 5.

[147] Fang F, Wu B, Qu Q. The clinical response and systemic effects of non-surgical periodontal therapy in end-stage renal disease patients: a 6-month randomized controlled clinical trial. J Clin Periodontol, 2015, 42(6): 537-546.